amlodipine has been researched along with Atherosclerotic Parkinsonism in 2 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaur, U | 1 |
| Das, P | 1 |
| Gambhir, IS | 1 |
| Chakrabarti, SS | 1 |
| Sempere, AP | 1 |
| Duarte, J | 1 |
| Cabezas, C | 1 |
| Coria, F | 1 |
| ClaverÃa, LE | 1 |
2 other studies available for amlodipine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
L-type calcium channel blockers and a symptom complex mimicking de Melo-Souza's syndrome.
Topics: Aged; Amlodipine; Calcium Channel Blockers; Calcium Channels, L-Type; Diagnosis, Differential; Femal | 2019 |
Parkinsonism induced by amlodipine.
Topics: Aged; Amlodipine; Female; Follow-Up Studies; Humans; Hypertension; Parkinson Disease, Secondary | 1995 |